MARKET

BMRN

BMRN

Biomarin Pharmaceutical Inc
NASDAQ
69.44
-1.16
-1.64%
After Hours: 69.44 0 0.00% 19:41 03/14 EDT
OPEN
70.41
PREV CLOSE
70.60
HIGH
70.41
LOW
68.42
VOLUME
1.27M
TURNOVER
--
52 WEEK HIGH
94.85
52 WEEK LOW
60.63
MARKET CAP
13.25B
P/E (TTM)
31.46
1D
5D
1M
3M
1Y
5Y
1D
AMRN's Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan
NASDAQ · 2d ago
Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"
NASDAQ · 3d ago
SpringWorks Shares Rise More Than 30% in 3 Months: Here's Why
NASDAQ · 3d ago
Wall Street Analysts Believe BioMarin (BMRN) Could Rally 36.57%: Here's is How to Trade
NASDAQ · 4d ago
Buy These 5 Top-Ranked Stocks to Play Likely Earnings Beat
NASDAQ · 4d ago
NVO Stock Down 9% as CagriSema Misses Target in Second Obesity Study
NASDAQ · 4d ago
PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study
NASDAQ · 4d ago
BEAM Down Despite Positive Initial Data From Genetic Disorder Study
NASDAQ · 4d ago
More
About BMRN
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.

Webull offers Biomarin Pharmaceutical Inc stock information, including NASDAQ: BMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMRN stock methods without spending real money on the virtual paper trading platform.